Patents by Inventor Richard Glickman

Richard Glickman has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Treatment of vascular, autoimmune and inflammatory diseases using low dosages of IMPDH inhibitors
    Patent number: 8957071
    Abstract: The disclosure provides methods and compositions for treating a vascular, autoimmune, and/or inflammatory disease, or a condition associated therewith, with a dose of an inosine monophosphate dehydrogenase (IMPDH) inhibitor effective to treat the vascular, autoimmune and/or inflammatory disease, or associated condition but that does not produce immunosuppression sufficient to reduce the risk of allograft rejection. These lower doses of the immunosuppressant avoid the adverse consequences of severe immunosuppression while providing effective treatment of the vascular, autoimmune and/or inflammatory disease.
    Type: Grant
    Filed: May 5, 2008
    Date of Patent: February 17, 2015
    Assignees: Aspreva Pharmaceuticals S.A., Aspreva Pharmaceuticals Corp.
    Inventors: Richard Glickman, Michael R. Hayden, Noel Hall
  • Treatment of Vascular, Autoimmune and Inflammatory Diseases Using Low Dosages of IMPDH Inhibitors
    Publication number: 20090088427
    Abstract: The disclosure provides methods and compositions for treating a vascular, autoimmune, and/or inflammatory disease, or a condition associated therewith, with a dose of an inosine monophosphate dehydrogenase (IMPDH) inhibitor effective to treat the vascular, autoimmune and/or inflammatory disease, or associated condition but that does not produce immunosuppression sufficient to reduce the risk of allograft rejection. These lower doses of the immunosuppressant avoid the adverse consequences of severe immunosuppression while providing effective treatment of the vascular, autoimmune and/or inflammatory disease.
    Type: Application
    Filed: May 5, 2008
    Publication date: April 2, 2009
    Inventors: Richard GLICKMAN, Michael R. Hayden, Noel Hall
  • Evidence-based quality improvement and risk management solutions method
    Publication number: 20060282286
    Abstract: A computer-implemented method includes determining a set of related medical activities based on received medical evidence, providing a set of tools, each tool corresponding to at least one of the related medical activities in the set, identifying a set of content blocks in each tool in the set of tools, including identifying content blocks that can be common to at least two tools, determining a medical condition of a patient, and selecting a first tool from the set of tools based on the medical condition.
    Type: Application
    Filed: June 14, 2005
    Publication date: December 14, 2006
    Inventors: Stephen Faris, Srinivasalu Ambati, Robert Vivo, William Reece, Skye Schulte, Karen McCloskey, Richard Glickman-Simon
  • Treatment of vascular, autoimmune and inflammatory diseases using low dosages of IMPDH inhibitors
    Publication number: 20060235009
    Abstract: The disclosure provides methods and compositions for treating a vascular, autoimmune, and/or inflammatory disease, or a condition associated therewith, with a dose of an inosine monophosphate dehydrogenase (IMPDH) inhibitor effective to treat the vascular, autoimmune and/or inflammatory disease, or associated condition but that does not produce immunosuppression sufficient to reduce the risk of allograft rejection. These lower doses of the immunosuppressant avoid the adverse consequences of severe immunosuppression while providing effective treatment of the vascular, autoimmune and/or inflammatory disease.
    Type: Application
    Filed: February 8, 2006
    Publication date: October 19, 2006
    Inventors: Richard Glickman, Michael Hayden, Noel Hall